Clinical Trial: The Parasite and Infestation Study

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07849907) titled 'The Parasite and Infestation Study' on Sept. 18. Brief Summary: Many people have evidence o... Read More

Clinical Trial: Phase I Study of JY1001 Injection

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848945) titled 'Phase I Study of JY1001 Injection' on Sept. 17. Brief Summary: The goal of this dose esclat... Read More

Clinical Trial: Brain Imaging of DSP-2342

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850102) titled 'Brain Imaging of DSP-2342' on Sept. 24. Brief Summary: The investigators aim to determine t... Read More

Clinical Trial: High-Intensity Interval Training and Progressive Muscle Relaxation as a Movement-Based Group Intervention for the Non-Pharmacological Prevention of Adolescent Migraine: A Controlled Pilot Study

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850622) titled 'High-Intensity Interval Training and Progressive Muscle Relaxation as a Movement-Based Group... Read More

Clinical Trial: Pilot Study of Individualized Neurovisual Rehabilitation Following Acquired Brain Injury

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07849582) titled 'Pilot Study of Individualized Neurovisual Rehabilitation Following Acquired Brain Injury' on... Read More

Clinical Trial: First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848334) titled 'First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults' on Aug. 07. Brie... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More

Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634... Read More

Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wit... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma (RASolute 309)

Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Vers... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»